1. Silverberg E, Lubera JA. Cancer Statistics, 1989; 39:3–20.
2. Veterans Administration Cooperative Urological Research Group (VACURG). Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet, 1967; 124:1011–1017.
3. Huggins C, Hodges CV. Studies of prostatic cancer: I. Effect of castration, estrogen and androgen injections on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res, 1941; 1:293–297.
4. Eisenberger M, O’Dwyer P, Friedman MA. Gonadotropin hormone-releasing hormone analogues: A new therapeutic approach for prostatic cancer. J Clin Oncol, 1986; 4:414–424.
5. Labrie F, Dupont A, Belanger A. Complete androgenic blockade for the treatment of prostate cancer. In: Devita VT, Hellman S, Rosenberg SH, editors. Important advances in oncology. Philadelphia: J.B. Lippincott, 1985; 193–217.